# AEF0217 First-in-Human Phase I Study in 3 Parts (Single and Multiple Ascending Doses, and Food Effect) in Healthy Subjects.

> **NCT05170737** · PHASE1 · COMPLETED · sponsor: **Aelis Farma** · enrollment: 68 (actual)

## Conditions studied

- Safety, Tolerability, Pharmacokinetics of AEF0217

## Interventions

- **DRUG:** AEF0217
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05170737
- **Lead sponsor:** Aelis Farma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2022-06-28
- **Final completion:** 2022-06-28
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2024-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05170737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05170737, "AEF0217 First-in-Human Phase I Study in 3 Parts (Single and Multiple Ascending Doses, and Food Effect) in Healthy Subjects.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05170737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*